EGFR and breast carcinoma: Human epidermal growth factor receptor (HER) overexpression is a biological signature of breast cancer, as this oncogenic receptor is also implicated with apoptosis avoidance and drug resistance via the coupling with the PI3K/Akt cell-signalling pathway [96,97,98,99].